Oncology Drug Shortages
US Pharm. 2025;50(4):27-34. ABSTRACT: Although the number of new drug shortages (DSs) has declined in recent years, the overall extent of DSs remains elevated because of continued supply-chain vulnerabilities. When DSs involve oncology drugs, available …